Drug
Pregabalin Controlled Release
Pregabalin Controlled Release: highest development phase Phase 1, developed by Pfizer. 5 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Pregabalin controlled release, 82.5 mg NCT01202435 | Phase 1 | Healthy |
| Pregabalin controlled release, 82.5 mg NCT01220219 | Phase 1 | Healthy |
| Pregabalin controlled release, 330 mg, low-fat NCT01257529 | Phase 1 | Healthy |
| Pregabalin controlled release, 330 mg, 400 to 500 calories NCT01270815 | Phase 1 | Healthy |
| Pregabalin controlled release, 82.5 mg NCT01009541 | Phase 1 | Healthy |
Latest
No recent events.
Follow Pregabalin Controlled Release on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.